On February 26, the Xuguan Advanced Manufacturing Functional Area in Suzhou New District officially released its "Three-Year Action Plan for Emerging Industries (2026-2028)." The plan centers on the theme of "leapfrog development of emerging industries," focusing on three main strategic directions: new materials, innovative pharmaceuticals, and embodied AI. With the goals of "doubling scale, achieving innovation breakthroughs, and leading in ecosystem development," the area aims to fully establish itself as a hub for Suzhou Advanced Materials Valley, a specialized cluster for innovative drugs, and a core demonstration zone for embodied AI applications, driving a comprehensive upgrade in the region's industrial capabilities.

This action plan is a key measure for Xuguan to implement national, provincial, and municipal strategies for cultivating new quality productive forces and advancing new industrialization. It also serves as a guiding framework based on its own resource endowments to seize opportunities in industrial transformation and reshape regional competitive advantages. According to the targets, Xuguan will adhere to the principle of "simultaneously improving quality and quantity while emphasizing both speed and effectiveness." By 2028, the total output value of emerging industries is expected to exceed 55 billion yuan, with an average annual growth rate maintained above 20%, and it aims to attract 30 key enterprises with core competitiveness and industry leadership. While leading in scale, the plan places greater emphasis on systematic upgrades in innovation capability, factor allocation, and ecosystem development. The goal is to high-standardly build nationally leading hubs: the Suzhou Advanced Materials Valley, the specialized cluster for innovative drugs, and the core demonstration zone for embodied AI applications, achieving a genuine transition from "following" to "leading."

The three major sectors will develop synergistically to build distinctive industrial clusters. In the new materials field, the target output value is over 40 billion yuan, focusing on electronic information, high-end equipment, and biomedical applications, aiming to establish a leading domestic R&D, pilot-scale testing, and industrialization base for advanced materials. In the innovative pharmaceuticals sector, the target output value is over 5 billion yuan, concentrating on peptide drugs and radionuclide diagnostic and therapeutic drugs, and building a comprehensive R&D and production chain. In the embodied AI field, the target output value is over 10 billion yuan, with efforts to overcome core components such as RV reducers and servo systems, break through common technologies like environmental perception and intelligent decision-making, create more than 20 benchmark application scenarios, and establish a core manufacturing and demonstration application zone representative of the industry.

To ensure the achievement of these goals, Xuguan will introduce a series of robust measures to support industrial development. It will implement a triple-drive strategy of "source innovation + technological攻关 +成果转化," supporting enterprises and academic institutions in conducting interdisciplinary research, striving for more original "from 0 to 1" breakthroughs in key core areas. A "targeted攻坚" investment promotion plan will be implemented to accelerate the strengthening of core links in the industrial chains for new materials, innovative pharmaceuticals, and embodied AI, aiming to add over 100 high-quality projects and 500,000 square meters of high-quality industrial space within three years. Guided by the principles of "digital intelligence, green development, and service orientation," the plan will promote deep industrial transformation, targeting the addition of 10 provincial-level advanced smart factories and 20 various-level green factories within three years. Financial support will be injected, with investment in the emerging industries sector aiming to exceed 6 billion yuan over three years.